
Company Information
Ask for more detail from the seller
Contact SupplierINCRELEX contains mecasermin, a recombinant human insulin-like growth factor 1 (rh-IGF-1) and is indicated for the long-term treatment of growth failure in children and adolescents aged from 2 to 18 years with confirmed severe primary insulin-like growth factor 1 deficiency (primary IGFD).